Literature DB >> 19291428

Cancer detection and treatment: the role of nanomedicines.

Justin LaRocque1, Dhruba J Bharali, Shaker A Mousa.   

Abstract

Nanotechnology is a field which has been at the forefront of research over the past two decades. The full potential of nanotechnology has yet to be fully realized. One subset of nanotechnology that has emerged is nanomedicine, which has been able to exploit the unique properties of nano-sized particles for therapeutics. Nanomedicine has the potential to increase the specific treatment of cancer cells while leaving healthy cells intact through the use of novel nanoparticles to seek and treat cancer in the human body. However, there are undoubtedly toxicities, which have not yet been fully elucidated. Various nano-carriers such as nanoshells, nanocrystals, nanopolymers, quantum dots, and dendrimers, and their role in early cancer detection and treatment have been discussed in this article.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19291428     DOI: 10.1007/s12033-009-9161-0

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  52 in total

Review 1.  Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy.

Authors:  R K Jain
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

2.  Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles.

Authors:  Konstantin Sokolov; Michele Follen; Jesse Aaron; Ina Pavlova; Anais Malpica; Reuben Lotan; Rebecca Richards-Kortum
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

3.  Immunotargeted nanoshells for integrated cancer imaging and therapy.

Authors:  Christopher Loo; Amanda Lowery; Naomi Halas; Jennifer West; Rebekah Drezek
Journal:  Nano Lett       Date:  2005-04       Impact factor: 11.189

4.  Cantilever arrays for multiplexed mechanical analysis of biomolecular reactions.

Authors:  Min Yue; Jeanne C Stachowiak; Arunava Majumdar
Journal:  Mech Chem Biosyst       Date:  2004-09

Review 5.  Emerging implications of nanotechnology on cancer diagnostics and therapeutics.

Authors:  Alex G Cuenca; Huabei Jiang; Steven N Hochwald; Matthew Delano; William G Cance; Stephen R Grobmyer
Journal:  Cancer       Date:  2006-08-01       Impact factor: 6.860

Review 6.  Exploiting the enhanced permeability and retention effect for tumor targeting.

Authors:  Arun K Iyer; Greish Khaled; Jun Fang; Hiroshi Maeda
Journal:  Drug Discov Today       Date:  2006-09       Impact factor: 7.851

7.  Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer.

Authors:  William J Gradishar; Sergei Tjulandin; Neville Davidson; Heather Shaw; Neil Desai; Paul Bhar; Michael Hawkins; Joyce O'Shaughnessy
Journal:  J Clin Oncol       Date:  2005-09-19       Impact factor: 44.544

8.  Probing the Cytotoxicity Of Semiconductor Quantum Dots.

Authors:  Austin M Derfus; Warren C W Chan; Sangeeta N Bhatia
Journal:  Nano Lett       Date:  2003-12-10       Impact factor: 11.189

Review 9.  Her2-positive breast cancer: herceptin and beyond.

Authors:  Windy Dean-Colomb; Francisco J Esteva
Journal:  Eur J Cancer       Date:  2008-11-18       Impact factor: 9.162

10.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Authors:  Y Matsumura; H Maeda
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

View more
  17 in total

Review 1.  Informatics and standards for nanomedicine technology.

Authors:  Dennis G Thomas; Fred Klaessig; Stacey L Harper; Martin Fritts; Mark D Hoover; Sharon Gaheen; Todd H Stokes; Rebecca Reznik-Zellen; Elaine T Freund; Juli D Klemm; David S Paik; Nathan A Baker
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-06-30

2.  [Gd@C(82)(OH)(22)](n) nanoparticles inhibit the migration and adhesion of glioblastoma cells.

Authors:  Jing Wang; Feng Gu; Ting Ding; Xiaoli Liu; Gengmei Xing; Yuliang Zhao; Ning Zhang; Yongjie Ma
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

Review 3.  Convergence of nanotechnology and cancer prevention: are we there yet?

Authors:  David G Menter; Sherri L Patterson; Craig D Logsdon; Scott Kopetz; Anil K Sood; Ernest T Hawk
Journal:  Cancer Prev Res (Phila)       Date:  2014-07-24

4.  Expression and significance of secreted protein acidic and rich in cysteine in human osteosarcoma.

Authors:  Yongkun Yang; Xiaohui Niu; Weifeng Liu; Hairong Xu
Journal:  Oncol Lett       Date:  2017-09-01       Impact factor: 2.967

5.  Passive targeting of nanoparticles to cancer: A comprehensive review of the literature.

Authors:  Remon Bazak; Mohamad Houri; Samar El Achy; Wael Hussein; Tamer Refaat
Journal:  Mol Clin Oncol       Date:  2014-07-23

6.  Cytotoxicity and DNA cleavage with core-shell nanocomposites functionalized by a KH domain DNA binding peptide.

Authors:  Remon Bazak; Jan Ressl; Sumita Raha; Caroline Doty; William Liu; Beau Wanzer; Seddik Abdel Salam; Samy Elwany; Tatjana Paunesku; Gayle E Woloschak
Journal:  Nanoscale       Date:  2013-12-07       Impact factor: 7.790

Review 7.  Cancer cell invasion: treatment and monitoring opportunities in nanomedicine.

Authors:  Omid Veiseh; Forrest M Kievit; Richard G Ellenbogen; Miqin Zhang
Journal:  Adv Drug Deliv Rev       Date:  2011-02-02       Impact factor: 15.470

8.  Nano-Targeted Delivery of Toremifene, an Estrogen Receptor-α Blocker in Prostate Cancer.

Authors:  Waseem Hariri; Thangirala Sudha; Dhruba J Bharali; Huadong Cui; Shaker A Mousa
Journal:  Pharm Res       Date:  2015-03-12       Impact factor: 4.200

Review 9.  Biomedical applications of functionalized fullerene-based nanomaterials.

Authors:  Ranga Partha; Jodie L Conyers
Journal:  Int J Nanomedicine       Date:  2009

Review 10.  Cancer active targeting by nanoparticles: a comprehensive review of literature.

Authors:  Remon Bazak; Mohamad Houri; Samar El Achy; Serag Kamel; Tamer Refaat
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-09       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.